Bring a 882 and Scantron 2088-E (R1) (Green or Blue).
Supplement to chapter 1
Supplement to chapter 3 (microscopy/stains/culturing)
Chapter 4 can go die. Okay no seriously, my raw notes are here and the password is “smc”, they are full of spelling errors and you have to make sense of them by reading them and figure out what slide he’s talking about at the time.
Short answer questions
How long do our responses need to be? “It’s not about length, I expect them to be complete. That is why the questions are given ahead of time. Bullet points are fine. If your language writing skills are somewhat bad, then it’s easier to just put bullet points.”
1. What are emerging infectious diseases and what are 5 factors that contribute to their existence? (Answer is in the first link for chapter 1 above)
2. Compare and contrast the theories of biogenesis and spontaneous genesis. Which is accepted as a correct explanation for organisms? Comment on the evidence for biogenesis. (Answer is in the fourth link for chapter 1 above)
3. What are the Five I’s? List these in the order as done. Comment on any two of the five I’s. What is the role of the five I’s in diagnosis and treatment? (Inoculation, Incubation, Isolation, Inspection, Identification, it’s from that handout)
4. What is a case history? What information should be provided in a case history? Comment on the role of a case history on the Dx/Tx of infectious diseases.
“You’ll always get a clinical requisition from me. Also, a case presentation. How something relates to diagnosis and treatment.”
Multiple choice questions on your exam: What is the difference between a signs and symptoms? Are both prevalent? GRAM STAINS AND SEQUENCE OF EVENTS WILL BE ON TEST. Know how to do a gram stain and how to interpret the information. Role of the gram stain in clinical applications (BE FAMILIAR WITH ALL THIS). “I expect you to know the critical values.” (#4 of chapter 3 above)
A friendly reminder on Tuesday the 13th, at 11:15am in Science 140 there’s a talk that’s part of the Distinguished science series on “Immune Cells in Cancer and Stem Cells” by Dr. Jewett, a researcher from UCLA.